We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Why is China Becoming a Microfluidics Manufacturing Superpower?

Why is China Becoming a Microfluidics Manufacturing Superpower?

Blog

Many Chinese microfluidics companies are emerging and expanding, and it could be game-changing for the industry. We spoke with Yole Développement analyst, Sébastien Clerc, to learn more.

Read More

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain

Say Hello to Regenerative Medicine and Goodbye to Back Pain

Blog

Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.

Read More

A Move Towards Precise Management of Bacterial Infections

A Move Towards Precise Management of Bacterial Infections

Blog

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer

Blog

During this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.

Read More

Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward

Antibody Engineering: Driving Therapeutic Discovery and Diagnostics Forward

Blog

We recently spoke to GenScript’s VP of Marketing, Eric Wang, to learn more about the company’s mission to “make people and nature healthier through biotechnology”. Eric discusses the key phases of antibody therapeutic discovery and development, GenScript’s role in advancing drug discovery research, and tells us about the company’s recently launched custom rabbit monoclonal antibody service.

Read More

Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis

Digital Pathology Solution Could Speed Up Prostate Cancer Diagnosis

Blog

To learn more about ContextVision, their move into the field of digital pathology, and how INIFY™ could help benefit pathologists and patients, we spoke to Lena Kajland Wilén, Director Business Unit Digital Pathology.

Read More

HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR

HPV-Positive Oropharyngeal Cancers: Predicting Treatment Response Using ddPCR

Blog

During this year’s AACR Annual Meeting we spoke to Julianna Supplee, Research Technician at the Robert and Renée Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute, to learn more about the team’s most recent study on the use of plasma HPV cell-free DNA as an early predictor of treatment response in patients with advanced oropharyngeal cancer.

Read More

Using Cell-free DNA as a Marker for Liver Cancer Diagnosis

Using Cell-free DNA as a Marker for Liver Cancer Diagnosis

Blog

During this year’s AACR conference we spoke to Kang Zhang, M.D., Ph.D. from the University of California, San Diego about the collaborative work he has been doing with the Laboratory for Advanced Medicine. He discusses their recent study findings on the use of a blood-based method to look at cell-free DNA as a marker for liver cancer diagnosis and prognosis.

Read More

Accelerating Proteome Analysis With PASEF: A Unique and Sensitive Technique

Accelerating Proteome Analysis With PASEF: A Unique and Sensitive Technique

Blog

Understanding the proteome is a fundamental challenge of biology. Here, Bruker Daltonics' Gary Kruppa and Scarlet Koch outline a new method, Parallel Accumulation Serial Fragmentation (PASEF) that offers faster, more sensitive and more robust proteome analysis, giving scientists the potential to discover low-level, biologically significant proteins and validate them in research.

Read More

Accelerating the Development of Organs-on-Chips

Accelerating the Development of Organs-on-Chips

Blog

Emulate, Inc. and AstraZeneca recently announced they have formed a collaborative partnership which will see Emulate's Organs-on-Chips technology embedded in AstraZeneca's Innovative Medicines and Early Development Biotech Unit.

Read More